CV Lab is the first incubator fully focused on cardiovascular innovation in Europe: it selects the most promising ideas and turns them into spin-offs that can be funded by international venture capital. We take the most promising ideas through patenting, prototyping and proof-of-concept, until we are ready to spin-off a new company and seek venture capital funding. We make the most of a network of entrepreneurs and experts with strong expertise in the biomedical sector. We work with the best industry specialists. We are a lean structure very close to researchers and to clinical needs. We are at ease in situations where enterprise risk is higher. We are open to all ideas, but we prefer early projects. We choose the most promising in terms of market potential, clinical need, innovative content and scientific evidence. We prioritize the most structured proposals, aiming to achieve proof-of-concept within 18-24 months and to become standard-of-care within 4 to 8 years.